Form 4: USANA Health Sciences Director Gilbert A. Fuller Reports Stock Unit Vesting

Director Gilbert A. Fuller reported the vesting of 490 restricted stock units into common stock of USANA Health Sciences on April 24, 2024.

Summary

• On April 24, 2024, Gilbert A. Fuller, a director of USANA Health Sciences Inc., reported the vesting of 490 restricted stock units.
• These units converted into 490 shares of common stock.
• The transaction was executed under transaction code 'M', indicating the exercise or conversion of a derivative security.
• Following the transaction, Fuller directly owns 490 shares of USANA common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to executive compensation, and it doesn't inherently indicate positive or negative sentiment.

Positives

• The vesting of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule was pre-determined, suggesting a structured compensation plan.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is typical for publicly traded companies like USANA Health Sciences.

Stakeholder Impact

• The vesting of stock units aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates